$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000143774921020184 Filed on August 16, 2021

Income Statement

Concept	2021 Q3	2021 Q2	2020 Q2
Revenue	$1.299M	$992.1K	$307.1K
YoY Change	37.69%	223.01%	-57.83%
Cost Of Revenue	$294.7K	$239.6K	$148.5K
YoY Change	39.25%	61.38%	-78.15%
Gross Profit	$1.004M	$752.5K	$158.7K
YoY Change	37.23%	374.21%	224.14%
Gross Profit Margin	77.31%	75.85%	51.67%
Selling, General & Admin	$1.386M	$1.374M	$1.212M
YoY Change	-7.03%	13.38%	14.48%
% of Gross Profit	137.98%	182.6%	763.72%
Research & Development	$612.6K	$491.0K	$318.6K
YoY Change	84.96%	54.11%	5.76%
% of Gross Profit	61.01%	65.24%	200.75%
Depreciation & Amortization	$67.58K	$70.27K	$20.00K
YoY Change	125.27%	251.35%	-93.55%
% of Gross Profit	6.73%	9.34%	12.6%
Operating Expenses	$1.998M	$1.865M	$1.531M
YoY Change	9.7%	21.86%	12.55%
Operating Profit	-$994.0K	-$1.113M	-$200.9K
YoY Change	-8.79%	453.78%	74.98%
Interest Expense	$0.00	$0.00	$567.5K
YoY Change	-100.0%	-100.0%	394.07%
% of Operating Profit
Other Income/Expense, Net	-$29.67K	-$49.17K	-$1.372M
YoY Change	-98.65%	-96.42%	4.64%
Pretax Income	-$1.024M	-$1.162M	-$1.570M
YoY Change	-68.89%	-26.01%	9.79%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.024M	-$1.162M	-$1.573M
YoY Change	-68.92%	-26.13%	10.31%
Net Earnings / Revenue	-78.81%	-117.09%	-512.05%
Basic Earnings Per Share	-$0.13	-$0.15
Diluted Earnings Per Share	-$131.4K	-$149.4K	-$601.5K
COMMON SHARES
Basic Shares Outstanding	7.825M	7.776M	21.60M
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q3	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.592M	$11.99M	$1.400M
YoY Change	-49.28%	756.61%	102.9%
Cash & Equivalents	$9.592M	$11.48M	$886.7K
Short-Term Investments	$0.00	$512.8K	$520.0K
Other Short-Term Assets	$53.50K	$49.50K	$79.63K
YoY Change	-15.43%	-37.84%	-42.53%
Inventory	$4.635M	$2.291M	$388.9K
Prepaid Expenses
Receivables	$1.541M	$1.348M	$315.3K
Other Receivables	$53.50K	$49.50K	$70.00K
Total Short-Term Assets	$16.77M	$17.29M	$2.285M
YoY Change	-17.65%	656.68%	-40.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$71.47K	$60.26K	$95.55K
YoY Change	-9.47%	-36.93%	-30.49%
Goodwill	$1.263M	$1.263M	$417.2K
YoY Change	9.35%	202.64%
Intangibles	$1.352M	$1.406M	$2.147M
YoY Change	-16.39%	-34.51%	1024.1%
Long-Term Investments	$482.8K
YoY Change
Other Assets	$227.3K	$201.2K	$190.0K
YoY Change	42.07%	5.91%	-34.48%
Total Long-Term Assets	$3.956M	$3.651M	$3.467M
YoY Change	8.84%	5.32%	-52.78%
TOTAL ASSETS
Total Short-Term Assets	$16.77M	$17.29M	$2.285M
Total Long-Term Assets	$3.956M	$3.651M	$3.467M
Total Assets	$20.73M	$20.94M	$5.752M
YoY Change	-13.63%	264.11%	-48.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.437M	$864.8K	$668.5K
YoY Change	356.86%	29.38%	-22.71%
Accrued Expenses	$699.4K	$575.2K	$380.5K
YoY Change	74.96%	51.19%	-46.73%
Deferred Revenue	$671.9K	$549.8K	$602.8K
YoY Change	-13.08%	-8.79%	104.85%
Short-Term Debt	$0.00	$0.00	$500.0K
YoY Change	-100.0%	-100.0%	-7.41%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.014M	$2.211M	$4.623M
YoY Change	54.41%	-52.17%	71.32%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$180.3K	$233.4K	$350.0K
YoY Change	-51.27%	-33.31%	-7.89%
Total Long-Term Liabilities	$180.3K	$233.4K	$346.1K
YoY Change	-50.73%	-32.55%	-9.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.014M	$2.211M	$4.623M
Total Long-Term Liabilities	$180.3K	$233.4K	$346.1K
Total Liabilities	$3.195M	$2.445M	$4.970M
YoY Change	37.81%	-50.81%	61.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$102.5M	-$101.5M	-$94.78M
YoY Change	4.56%	7.12%	20.95%
Common Stock	$783.00	$782.00	$2.218K
YoY Change	-87.45%	-64.74%	55.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.53M	$18.50M	$782.5K
YoY Change
Total Liabilities & Shareholders Equity	$20.73M	$20.94M	$5.752M
YoY Change	-13.63%	264.11%	-48.44%

Cashflow Statement

Concept	2021 Q3	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$1.024M	-$1.162M	-$1.573M
YoY Change	-68.92%	-26.13%	10.31%
Depreciation, Depletion And Amortization	$67.58K	$70.27K	$20.00K
YoY Change	125.27%	251.35%	-93.55%
Cash From Operating Activities	-$1.866M	-$2.042M	-$950.0K
YoY Change	8.47%	115.0%	126.19%
INVESTING ACTIVITIES
Capital Expenditures	-$22.18K	-$5.700K	$0.00
YoY Change	121.8%		-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$1.900M
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$22.18K	-$5.700K	-$1.910M
YoY Change	-92.35%	-99.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-5.230K	3.070M
YoY Change	-100.0%	-100.17%	372.31%
NET CHANGE
Cash From Operating Activities	-1.866M	-2.042M	-950.0K
Cash From Investing Activities	-22.18K	-5.700K	-1.910M
Cash From Financing Activities	0.000	-5.230K	3.070M
Net Change In Cash	-1.888M	-2.053M	210.0K
YoY Change	-110.78%	-1077.81%	-8.7%
FREE CASH FLOW
Cash From Operating Activities	-$1.866M	-$2.042M	-$950.0K
Capital Expenditures	-$22.18K	-$5.700K	$0.00
Free Cash Flow	-$1.843M	-$2.037M	-$950.0K
YoY Change	7.8%	114.4%	131.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7824971
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7819661
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7819661
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7814572
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7814572
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2020Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2021Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2021Q2	bkyi	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	0
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11479691	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16993096	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1347677	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	548049	USD
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	49500	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	60453	USD
CY2021Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	295000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	2290628	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	330947	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1612099	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	201507	USD
CY2021Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821	USD
CY2020Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	17292416	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	18941873	USD
CY2021Q2	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	53873	USD
CY2020Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	58882	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60259	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	81793	USD
CY2021Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	192509	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	165315	USD
CY2021Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712	USD
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712	USD
CY2021Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	295000	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	372303	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	487325	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1406112	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1514146	USD
CY2021Q2	us-gaap	Goodwill Goodwill	1262526	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2211252	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1876303	USD
CY2021Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	71037	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	44987	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162373	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	264163	USD
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	233410	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	309150	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1262526	USD
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	3651294	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3578699	USD
CY2021Q2	us-gaap	Assets Assets	20943710	USD
CY2020Q4	us-gaap	Assets Assets	22520572	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	864847	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	244158	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	575214	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	508487	USD
CY2021Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	232000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	549792	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	657349	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	221399	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	234309	USD
CY2021Q2	us-gaap	Liabilities Liabilities	2444662	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2185453	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	782	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	782	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	120021069	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	119844026	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101522803	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99509689	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	18499048	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	20335119	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20943710	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22520572	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	992090	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	307142	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2880728	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	829627	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	239569	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	148454	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1006204	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	272717	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	752521	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	158688	USD
	us-gaap	Gross Profit GrossProfit	1874524	USD
	us-gaap	Gross Profit GrossProfit	556910	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1374084	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1211928	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2890482	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2593327	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	490952	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	318573	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	932603	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	655462	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1865036	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	1530501	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-50000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	-0	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	567516	USD
	us-gaap	Interest Expense InterestExpense	18000	USD
	us-gaap	Operating Expenses OperatingExpenses	3823085	USD
	us-gaap	Operating Expenses OperatingExpenses	3248789	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1112515	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1371813	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1948561	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2691879	USD
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	832	USD
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	25801	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3447	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	25802	USD
CY2021Q2	bkyi	Government Grant Income GovernmentGrantIncome	0	USD
CY2020Q2	bkyi	Government Grant Income GovernmentGrantIncome	340819	USD
	bkyi	Government Grant Income GovernmentGrantIncome	0	USD
	bkyi	Government Grant Income GovernmentGrantIncome	340819	USD
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-50000	USD
CY2020Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	us-gaap	Interest Expense InterestExpense	2118657	USD
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-499076	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-49168	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-200896	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-64553	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2251112	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1161683	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-1572709	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2013114	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4942991	USD
CY2021Q2	us-gaap	Dividends Paidinkind DividendsPaidinkind	-0	USD
CY2020Q2	us-gaap	Dividends Paidinkind DividendsPaidinkind	-0	USD
	us-gaap	Dividends Paidinkind DividendsPaidinkind	-0	USD
	us-gaap	Dividends Paidinkind DividendsPaidinkind	112686	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1161683	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1572709	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2013114	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5055677	USD
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.60
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.24
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7776190
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2608108
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7774946
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2253867
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	20335119	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7510	USD
CY2021Q1	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	2709	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	133638	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	641215	USD
CY2020Q1	bkyi	Stock Issued During Period Value Conversion Of Warrant StockIssuedDuringPeriodValueConversionOfWarrant	1458000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1500000	USD
CY2020Q1	bkyi	Deemed Dividend Related To Down Round Features DeemedDividendRelatedToDownRoundFeatures	0	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	512719	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-3370282	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-1411021	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15007	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	145333	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2289000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33177	USD
CY2020Q2	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	-199328	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-1572709	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	782453	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2013114	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4942991	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-851431	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	19622127	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5505	USD
CY2021Q2	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	2519	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	-0	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35618	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1161683	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	18499048	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-2285173	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1032500	USD
CY2020Q1	bkyi	Commitment Fee Adjustment Equity Impact CommitmentFeeAdjustmentEquityImpact	-900000	USD
	us-gaap	Depreciation Depreciation	37234	USD
	us-gaap	Depreciation Depreciation	39919	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	108034	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12189	USD
	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	5009	USD
	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	0	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	48997	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	73660	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	398929	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	981529	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	115022	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	92632	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-499076	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-50000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-0	USD
	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	0	USD
	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	641215	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	96984	USD
	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	169256	USD
	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	640551	USD
	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	13015	USD
	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	15007	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	849628	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4549	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-10953	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-31307	USD
	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	76191	USD
	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	18486	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1959681	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-40221	USD
	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-0	USD
	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-5028	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1410592	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-19241	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	620689	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-298797	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	66727	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-192917	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-81507	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-9601	USD
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-114700	USD
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-89787	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5242477	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1969640	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	-0	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2000000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	100747	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	512821	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	-0	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	516121	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15700	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3489	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15700	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1906042	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3958000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5228	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	398412	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1458000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	250000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	211984	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	-0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	122271	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-255228	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4683333	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5513405	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	807651	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16993096	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79013	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11479691	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	886664	USD
	us-gaap	Interest Paid Net InterestPaidNet	18000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired	0	USD
	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired	184792	USD
	bkyi	Business Combination Prepaid Expenses Acquired BusinessCombinationPrepaidExpensesAcquired	0	USD
	bkyi	Business Combination Prepaid Expenses Acquired BusinessCombinationPrepaidExpensesAcquired	9485	USD
	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired	0	USD
	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired	36467	USD
	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired	0	USD
	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired	2005000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	417171	USD
	bkyi	Business Combination Issuance Of Notes Payable BusinessCombinationIssuanceOfNotesPayable	0	USD
	bkyi	Business Combination Issuance Of Notes Payable BusinessCombinationIssuanceOfNotesPayable	500000	USD
	bkyi	Business Combination Accrued Expenses Acquired BusinessCombinationAccruedExpensesAcquired	0	USD
	bkyi	Business Combination Accrued Expenses Acquired BusinessCombinationAccruedExpensesAcquired	494	USD
	bkyi	Business Combination Deferred Revenue Acquired BusinessCombinationDeferredRevenueAcquired	0	USD
	bkyi	Business Combination Deferred Revenue Acquired BusinessCombinationDeferredRevenueAcquired	253168	USD
	bkyi	Operating Lease Liability Assumed Under Asc842 OperatingLeaseLiabilityAssumedUnderAsc842	0	USD
	bkyi	Operating Lease Liability Assumed Under Asc842 OperatingLeaseLiabilityAssumedUnderAsc842	79107	USD
	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees	0	USD
	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees	277833	USD
	bkyi	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	0	USD
	bkyi	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	1388339	USD
	bkyi	Debt Discount Issued With Convertible Note DebtDiscountIssuedWithConvertibleNote	0	USD
	bkyi	Debt Discount Issued With Convertible Note DebtDiscountIssuedWithConvertibleNote	551250	USD
	us-gaap	Dividends Paidinkind DividendsPaidinkind	0	USD
	us-gaap	Dividends Paidinkind DividendsPaidinkind	112686	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Stock Issued1 StockIssued1	3789000	USD
	bkyi	Beneficial Conversion Feature BeneficialConversionFeature	0	USD
	bkyi	Beneficial Conversion Feature BeneficialConversionFeature	641215	USD
	bkyi	Legal And Commitment Fees Related To Debt And Equity Included In Accounts Payable LegalAndCommitmentFeesRelatedToDebtAndEquityIncludedInAccountsPayable	0	USD
	bkyi	Legal And Commitment Fees Related To Debt And Equity Included In Accounts Payable LegalAndCommitmentFeesRelatedToDebtAndEquityIncludedInAccountsPayable	122714	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Reclassification</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Reclassifications occurred to certain prior year amounts in order to conform to the current year classifications. The reclassifications have <em style="font: inherit;">no</em> effect on the reported net loss. </p>
	bkyi	Monthly Cash Requirement To Conduct Operations And Pay Dividend Obligations MonthlyCashRequirementToConductOperationsAndPayDividendObligations	735000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2880728	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24000000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11479691	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	992090	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	307142	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2880728	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	829627	USD
CY2021Q1	bkyi	Percentage Of Support And Maintenance Revenue To License Cost PercentageOfSupportAndMaintenanceRevenueToLicenseCost	0.18	pure
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	621000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	702000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	124000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	430000	USD
CY2021Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1411462	USD
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	561834	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-50000	USD
CY2021Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	49500	USD
CY2020Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	60453	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1347677	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	548049	USD
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41123	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	142839	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	182271	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	655558	USD
CY2021Q2	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	99000	USD
CY2020Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	241715	USD
CY2021Q2	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	49500	USD
CY2020Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	181262	USD
	bkyi	Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter	150000	USD
CY2021Q2	bkyi	Factoring Fees FactoringFees	18900	USD
CY2020Q2	bkyi	Factoring Fees FactoringFees	33230	USD
	bkyi	Factoring Fees FactoringFees	32247	USD
	bkyi	Factoring Fees FactoringFees	65230	USD
CY2020Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	295000	USD
	us-gaap	Receivable With Imputed Interest Effective Yield Interest Rate ReceivableWithImputedInterestEffectiveYieldInterestRate	0.05	pure
CY2021Q2	bkyi	Prepaid Deposit For Hardware Devices PrepaidDepositForHardwareDevices	1400000	USD
CY2021Q2	bkyi	Prepaid Deposit For Inventory PrepaidDepositForInventory	1446471	USD
CY2020Q4	bkyi	Prepaid Deposit For Inventory PrepaidDepositForInventory	66995	USD
CY2021Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	107786	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	64178	USD
CY2021Q2	us-gaap	Prepaid Insurance PrepaidInsurance	16428	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	45468	USD
CY2021Q2	bkyi	Prepaid Software License PrepaidSoftwareLicense	41414	USD
CY2020Q4	bkyi	Prepaid Software License PrepaidSoftwareLicense	24866	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1612099	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	201507	USD
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2092622	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	221130	USD
CY2021Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	198006	USD
CY2019Q3	bkyi	Class Of Warrant Or Right Recorded As Debt Discount ClassOfWarrantOrRightRecordedAsDebtDiscount	595662	USD
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	109817	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	2290628	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	330947	USD
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Commitment Fees PaymentsOfStockIssuanceCostsCommitmentFees	50000	USD
CY2019Q3	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	33334
CY2019Q3	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	400000	USD
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Banker Fees PaymentsOfStockIssuanceCostsBankerFees	193500	USD
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Legal Fees PaymentsOfStockIssuanceCostsLegalFees	71330	USD
CY2020Q1	us-gaap	Share Price SharePrice	6.08
CY2020Q2	us-gaap	Share Price SharePrice	5.20
CY2020Q3	bkyi	Stock Returned During The Period Shares Commitment Fee StockReturnedDuringThePeriodSharesCommitmentFee	75000
CY2020Q2	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	133333	USD
CY2020Q2	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	14368
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	9.28
CY2020Q2	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	100000	USD
CY2020Q2	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	17071
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.86
	us-gaap	Dividends Paidinkind DividendsPaidinkind	112686	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1161683	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1572709	USD
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	63973	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	127946	USD
CY2021Q2	us-gaap	Lease Cost LeaseCost	63973	USD
	us-gaap	Lease Cost LeaseCost	127946	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	372303	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	221399	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162373	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	383772	USD
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M29D
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550	pure
	us-gaap	Operating Lease Payments OperatingLeasePayments	119225	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	129352	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	187594	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	89226	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	406172	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	22400	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	383772	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1161683	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-1572709	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2013114	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4942991	USD
CY2021Q2	us-gaap	Dividends Paidinkind DividendsPaidinkind	-0	USD
CY2020Q2	us-gaap	Dividends Paidinkind DividendsPaidinkind	-0	USD
	us-gaap	Dividends Paidinkind DividendsPaidinkind	-0	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2013114	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5055677	USD
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2020Q1	bkyi	Stock Issued During Period Shares Warrants Exercises StockIssuedDuringPeriodSharesWarrantsExercises	121500
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	12.00
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1458000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	bkyi	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	0
CY2015Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	8681
CY2015Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	28.80
CY2015Q3	us-gaap	Dividends Paidinkind DividendsPaidinkind	41688	USD

Files In Submission

Name	View Source	Status
0001437749-21-020184-index-headers.html	Edgar Link	pending
0001437749-21-020184-index.html	Edgar Link	pending
0001437749-21-020184.txt	Edgar Link	pending
0001437749-21-020184-xbrl.zip	Edgar Link	pending
bkyi-20210630.xsd	Edgar Link	pending
bkyi-20210630_cal.xml	Edgar Link	unprocessable
bkyi-20210630_def.xml	Edgar Link	unprocessable
bkyi-20210630_lab.xml	Edgar Link	unprocessable
bkyi-20210630_pre.xml	Edgar Link	unprocessable
bkyi20210630_10q.htm	Edgar Link	pending
bkyi20210630_10q_htm.xml	Edgar Link	completed
ex_273839.htm	Edgar Link	pending
ex_273840.htm	Edgar Link	pending
ex_273841.htm	Edgar Link	pending
ex_273842.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2021 Q3 Form 10-Q Financial Statement

#000143774921020184 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2021 Q3 Form 10-Q Financial Statement

#000143774921020184 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi